Esteban Braggio, PhD

Associate Consultant II
Mayo Clinic

N/A

Poster(s):

• 1122 - Treatment Patterns and Outcomes of Patients with TP53-Mutated Chronic Lymphocytic Leukemia

• 1134 - High deletion burden identified by whole genome sequencing is associated with enhanced risk in del17p CLL patients

• 1160 - Clinical outcomes in patients with chronic lymphocytic leukemia (CLL) treated with venetoclax-based regimens

• 2006 - Impact of nucleotide metabolism on CLL B-cell pathobiology and CLL disease progression